Drug Trial Radar · NCT00886470
ST266 Versus Standard Care In Treating Partial Thickness Burns
Last checked: Nov 19, 2026Latest source record: May 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
16
Actual
Start
Jun 2009
Primary completion
Mar 2010
Study completion Mar 2010
Sponsor
- Lead sponsor
- Noveome Biotherapeutics, formerly StemnionIndustry
- Sponsor type
- Industry
- First posted
- Apr 23, 2009
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this protocol is to perform a safety and dose-determination efficacy clinical trial in patients having a degree of partial-thickness burn wounds. The trial will be a prospectively randomized and double-blind trial of ST266 compared with standardized care using 0.9% NaCl (normal saline) solution in the same three treatment regimens.
Conditions
- Burns
Interventions
ST266Biological
ST266 is a clear liquid containing more than 200 proteins, cytokines, and growth factors in solution. Patients will be treated for 21 days unless both wounds have healed prior to 21 days, at which time a punch biopsy of the epithelialized area of each wound will be performed. A study evaluation visit for assessment of the biopsy site will occur on day 28 or within 7 days of the punch biopsies, whichever occurs first. Six months after the punch biopsy, the patient will return to the burn center for a final examination and photographs of the study wounds.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary endpoint will be the percentage of each wound that has epithelialized during the 21-day treatment period comparing the ST266-treated wound with the saline-treated wound.Time frame: 21 days
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
University of South Alabama Dept. of Surgery
Mobile, Alabama
LAC - USC Medical Center
Los Angeles, California
Shands Burn Center at the University of Florida
Gainesville, Florida
University of South Florida / Tampa General Hospital
Tampa, Florida
Loyola University Medical Center
Maywood, Illinois
University of Kentucky Chandler Medical Center
Lexington, Kentucky
Johns Hopkins Burn Center
Baltimore, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
University of Missouri Health Care
Columbia, Missouri
Acute & Critical Care Surgery Barnes Jewish Hospital, Washington University Medical Center
St Louis, Missouri
University of Rochester
Rochester, New York
MetroHealth Medical Center
Cleveland, Ohio
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania
John S. Dunn Sr. Burn Center
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.